Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,038 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors

NCT00088101

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hematological Malignancies, +15 more
Locations
  • Wilshire Oncology Medical Group Pomona, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • Tufts New England Medical Center Boston, Massachusetts, United States
View Trial Details
Completed

Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy

NCT00185393

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Antwerp, Belgium
  • Bruges, Belgium
  • Brussels, Belgium
  • Ghent, Belgium
View all 95 locations
View Trial Details
Completed

Glivec in Ph Positive Lymphoblastic Leukemia

NCT00388895

Conditions
Acute Lymphoblastic Leukemia, Cromosome Philadelphia Positive, Hematologic Diseases, +10 more
Locations
  • Hospital General de Alicante Alicante, Spain
  • Hospital "Duran I Reynals" Barcelona, Spain
  • Hospital "Santa Creu i Sant Pau" Barcelona, Spain
  • Hospital Clínico y Provincial de Barcelona Barcelona, Spain
View all 28 locations
View Trial Details

Related conditions